Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Thomas Luft, MD PhD, Hao Dai, Aleksandar Radujkovic, MD, David Schult, Joshua Majer-Lauterbach, Olga Blau, MD PhD, Lars Bullinger, Sihe Jiang, Carsten Müller-Tidow, MD, Peter Dreger, Olaf Penack, MD

Blood (2019) 134 (Supplement_1): 4487.

https://doi.org/10.1182/blood-2019-124284

Published: 2019

Journal Articles

Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse

Blood (2019) 134 (Supplement_1): 3806.

https://doi.org/10.1182/blood-2019-129018

Published: 2019

Journal Articles

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Blood (2019) 134 (Supplement_1): 4483.

https://doi.org/10.1182/blood-2019-124065

Published: 2019

Journal Articles

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Paolo Bernasconi, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Oscar Borsani, MD

Blood (2019) 134 (Supplement_1): 5649.

https://doi.org/10.1182/blood-2019-125608

Published: 2019

Journal Articles

Vascular and Parenchymal Alterations of the Liver and Liver Surveillance in Patients Who Received Inotuzumab Ozogamicin As the Standard of Care for Relapse/Refractory Acute Lymphoblastic Leukemia

Giovanni Marconi, Federico Ravaioli, MD, Giovanni Martinelli, MD, Elton Dajti, Maria Chiara Abbenante, MD, Chiara Sartor, MD, Luigina Vanessa Alemanni, MD, Jacopo Nanni, MD, Sarah Parisi, MD PhD, Giovanni Marasco, MD, Gianluca Cristiano, MD, Amanda Vestito, MD, Francesca Bonifazi, Stefania Paolini, MD PhD, Antonio Curti, MD PhD, Davide Festi, MD, Michele Cavo, Cristina Papayannidis, Antonio Colecchia, MD

Blood (2019) 134 (Supplement_1): 1343.

https://doi.org/10.1182/blood-2019-130632

Published: 2019

Journal Articles

Bile Acids Induce Platelet Activation Leading to Degranulation and a Prothrombotic Phenotype

Joachim Zobel, Tanja Strini, Martin Tischitz, Sina Pohl, Theresa Greimel, Jörg Jahnel, Axel Schlagenhauf

Blood (2019) 134 (Supplement_1): 4887.

https://doi.org/10.1182/blood-2019-126095

Published: 2019

Journal Articles

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Clinton Lewis, MD, Haesook T. Kim, PhD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Rizwan Romee, MD, Brett Glotzbecker, Prashant Nageshwar, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Paul Richardson, Robert J. Soiffer, MD, Vincent T. Ho, MD

Blood (2018) 132 (Supplement 1): 3376.

https://doi.org/10.1182/blood-2018-99-113130

Published: 2018

Journal Articles

Liver Injury after Autologous Hematopoietic Stem Cell Transplant: DILI and SOS

Alessandro de Moura Almeida, MD, Helma Pinchemel Cotrim, PhD, Dayanne Costa Fonseca, MD, Dora Marcia Alencar, MD, Daniela Dourado Dutra, MD, Herbert Henrique de Melo Santos, MD, Monica Botura, MD, Marco Aurelio Salvino, PhD, Maria da Gloria Bomfim Arruda, PhD

Blood (2018) 132 (Supplement 1): 2161.

https://doi.org/10.1182/blood-2018-99-120015

Published: 2018

Journal Articles

A Transient Induction of Blood-Circulating Bile Acid Is a Therapeutic Marker and Target of Chemotherapy-Oriented Myelosuppression

Valgardur Sigurdsson, PhD, Youichi Haga, MD PhD, Hajime Takei, PhD, Chizuko Okamatsu-Haga, MD PhD, Visnja Radulovic, PhD, Mark Van Der Garde, PhD, Mitsuyoshi Suzuki, MD PhD, Svetlana Soboleva, Hiroshi Nittono, MD PhD, Akira Ohara, MD, Kenichi Miharada, PhD

Blood (2017) 130 (Supplement 1): 3344.

https://doi.org/10.1182/blood.V130.Suppl_1.3344.3344

Published: 2017

Journal Articles

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Shinsuke Takagi, MD PhD, Mitsuhiro Yuasa, MD, Naoyuki Uchida, MD PhD, Kyosuke Yamaguchi, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Koji Izutsu, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 5747.

https://doi.org/10.1182/blood.V128.22.5747.5747

Published: 2016

Journal Articles

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Hiroshi Okamura, MD, Mitsutaka Nishimoto, MD,PhD, Takahiko Nakane, MD, PhD, Hideo Koh, MD,PhD, Yasuhiro Nakashima, MD, PhD, Yasunobu Takeoka, MD, PhD, Mika Nakamae, MD,PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD, Hirohisa Nakamae, MD PhD

Blood (2016) 128 (22): 5755.

https://doi.org/10.1182/blood.V128.22.5755.5755

Published: 2016

Journal Articles

Diagnosis of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease of the Liver: Problems of Interpretation

Liisa Volin, MD PhD, Riitta Niittyvuopio, MD PhD, Jouni Heiskanen, MD, Vesa Lindstrom, MD, Leila Sahlstedt, MD PhD, Tapani Ruutu, MD PhD

Blood (2015) 126 (23): 1918.

https://doi.org/10.1182/blood.V126.23.1918.1918

Published: 2015

Journal Articles

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Blood (2015) 126 (23): 4332.

https://doi.org/10.1182/blood.V126.23.4332.4332

Published: 2015

Journal Articles

Persisting Hyperbilirubinemia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Chronically Treated with Eculizumab: The Role of Hepatocanalicular Transport Variants

Ferras Alashkar, MD, Ali Canbay, MD, Dörte Herich-Terhürne, Ulrich Dührsen, MD, Frank Lammert, MD, Alexander Röth, MD

Blood (2015) 126 (23): 940.

https://doi.org/10.1182/blood.V126.23.940.940

Published: 2015

Journal Articles

The Risk of Sinusoidal Obstruction Syndrome (SOS) in Allogeneic Hematopoietic Stem Cell Transplantation after Prior Gemtuzumab Ozogamicin Treatment: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Giorgia Battipaglia, Myriam Labopin, MD, Anna Candoni, MD, Renato Fanin, Jean El Cheikh, Didier Blaise, Mauricette Michallet, MD PhD, Annalisa Ruggeri, MD PhD, Natalie Contentin, Josep Ribera, MD PhD, Michael Stadler, MD, Jorge Sierra, MD PhD, Peter A. Von Dem Borne, Adrian Bloor, FRCPath, Gerard Socie, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3110.

https://doi.org/10.1182/blood.V126.23.3110.3110

Published: 2015

Journal Articles

Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

Patricia Huezo-Diaz, PhD, Chakradhara Rao Uppungunduri, PhD, Anuj Kumar Tyagi, PhD, Mohamed Aziz Rezgui, MsC, Fabienne Gumy-Pause, MD, Michel Duval, MD, Henrique Bittencourt, MD, Maja Krajinovic, MD, Marc Ansari, MD

Blood (2012) 120 (21): 3025.

https://doi.org/10.1182/blood.V120.21.3025.3025

Published: 2012

Journal Articles

Effectiveness of Ursodeoxycholic Acid As Prophylactic Agent Against Hepatic Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Treatment of Hematological Malignancies

Hong Yen HY Ng, B.Sc(Pharm)(Hons), BCOP, Mui Fong MF Chong, BSc (Pharm)(Hons), Jielin JL Song, BSc (Pharm)(Hons), William YK Hwang, MBBS, FRCP, FAMS, Yeh Ching Linn, MD, Yvonne SM Loh, MBBS, MRCP, Aloysius YL Ho, Yeow-Tee YT Goh, MD

Blood (2012) 120 (21): 4165.

https://doi.org/10.1182/blood.V120.21.4165.4165

Published: 2012

Journal Articles

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Tapani Ruutu, MD PhD, Eeva Juvonen, MD PhD, Mats Remberger, MD PhD, Kari Remes, MD PhD, Liisa Volin, Jonas Mattsson, MD PhD, Anne Nihtinen, MD, Hans Hagglund, MD PhD, Olle Ringden, MD PhD

Blood (2011) 118 (21): 488.

https://doi.org/10.1182/blood.V118.21.488.488

Published: 2011

Journal Articles

Hepatic Sinusoidal Obstruction Syndrome After Allogenetic Hematopoietic Stem Cell Transplantation in Adult Acquired Aplastic Anemia

Hawk Kim, Sung-Soo Yoon, Chul Won Jung, Sang Kyun Sohn, Young Don Joo, M.D., Byung Soo Kim, MD, PhD, Sung Hyun Kim, MD, PhD, Sung-Hwa Bae, MD, Ho-Jin Shin, Jong-Ho Won, Deog-Yeon Jo, MD, PhD, Jae Hoo Park, Kyoo-Hyung Lee, M.D.

Blood (2011) 118 (21): 3012.

https://doi.org/10.1182/blood.V118.21.3012.3012

Published: 2011

Journal Articles

A Retrospective Comparison of Tacrolimus Vs. Cyclosporine for Immunosuppression After Allogeneic Hematopoietic Cell Transplantation with G-CSF-Mobilized Blood Cells

Yoshihiro Inamoto, Mary E.D. Flowers, Frederick R. Appelbaum, Paul A. Carpenter, H. Joachim Deeg, Kristine C. Doney, Terrence Furlong, Hans-Peter Kiem, Stephanie J. Lee, Marco Mielcarek, Richard A. Nash, Rainer F. Storb, Robert P. Witherspoon, Barry E. Storer, Paul J. Martin

Blood (2010) 116 (21): 2319.

https://doi.org/10.1182/blood.V116.21.2319.2319

Published: 2010

NARROW

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Vascular and Parenchymal Alterations of the Liver and Liver Surveillance in Patients Who Received Inotuzumab Ozogamicin As the Standard of Care for Relapse/Refractory Acute Lymphoblastic Leukemia

Bile Acids Induce Platelet Activation Leading to Degranulation and a Prothrombotic Phenotype

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Liver Injury after Autologous Hematopoietic Stem Cell Transplant: DILI and SOS

A Transient Induction of Blood-Circulating Bile Acid Is a Therapeutic Marker and Target of Chemotherapy-Oriented Myelosuppression

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Diagnosis of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease of the Liver: Problems of Interpretation

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Persisting Hyperbilirubinemia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Chronically Treated with Eculizumab: The Role of Hepatocanalicular Transport Variants

The Risk of Sinusoidal Obstruction Syndrome (SOS) in Allogeneic Hematopoietic Stem Cell Transplantation after Prior Gemtuzumab Ozogamicin Treatment: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

Effectiveness of Ursodeoxycholic Acid As Prophylactic Agent Against Hepatic Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Treatment of Hematological Malignancies

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Hepatic Sinusoidal Obstruction Syndrome After Allogenetic Hematopoietic Stem Cell Transplantation in Adult Acquired Aplastic Anemia

A Retrospective Comparison of Tacrolimus Vs. Cyclosporine for Immunosuppression After Allogeneic Hematopoietic Cell Transplantation with G-CSF-Mobilized Blood Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only